nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—Methocarbamol—CA1—stomach cancer	0.0173	0.45	CrCbGaD
Ranolazine—Bevantolol—ADRB1—stomach cancer	0.00491	0.128	CrCbGaD
Ranolazine—Bevantolol—ADRB2—stomach cancer	0.00413	0.107	CrCbGaD
Ranolazine—Carvedilol—VEGFA—stomach cancer	0.00335	0.0871	CrCbGaD
Ranolazine—Carvedilol—ADRB1—stomach cancer	0.00224	0.0583	CrCbGaD
Ranolazine—Carvedilol—ADRB2—stomach cancer	0.00189	0.049	CrCbGaD
Ranolazine—Propranolol—ADRB1—stomach cancer	0.0017	0.0443	CrCbGaD
Ranolazine—Propranolol—HTR1A—stomach cancer	0.00153	0.0396	CrCbGaD
Ranolazine—Propranolol—ADRB2—stomach cancer	0.00143	0.0373	CrCbGaD
Ranolazine—Palpitations—Docetaxel—stomach cancer	0.00137	0.00143	CcSEcCtD
Ranolazine—Haematuria—Methotrexate—stomach cancer	0.00137	0.00142	CcSEcCtD
Ranolazine—Loss of consciousness—Docetaxel—stomach cancer	0.00137	0.00142	CcSEcCtD
Ranolazine—Pancreatitis—Doxorubicin—stomach cancer	0.00136	0.00142	CcSEcCtD
Ranolazine—Weight decreased—Epirubicin—stomach cancer	0.00136	0.00142	CcSEcCtD
Ranolazine—Cough—Docetaxel—stomach cancer	0.00136	0.00141	CcSEcCtD
Ranolazine—Epistaxis—Methotrexate—stomach cancer	0.00135	0.00141	CcSEcCtD
Ranolazine—Vertigo—Capecitabine—stomach cancer	0.00135	0.00141	CcSEcCtD
Ranolazine—Syncope—Capecitabine—stomach cancer	0.00135	0.0014	CcSEcCtD
Ranolazine—Leukopenia—Capecitabine—stomach cancer	0.00135	0.0014	CcSEcCtD
Ranolazine—Palpitations—Capecitabine—stomach cancer	0.00133	0.00138	CcSEcCtD
Ranolazine—Loss of consciousness—Capecitabine—stomach cancer	0.00132	0.00138	CcSEcCtD
Ranolazine—Pancytopenia—Doxorubicin—stomach cancer	0.00132	0.00137	CcSEcCtD
Ranolazine—Renal failure—Epirubicin—stomach cancer	0.00132	0.00137	CcSEcCtD
Ranolazine—Asthenia—Irinotecan—stomach cancer	0.00132	0.00137	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00131	0.00137	CcSEcCtD
Ranolazine—Cough—Capecitabine—stomach cancer	0.00131	0.00137	CcSEcCtD
Ranolazine—Dysuria—Doxorubicin—stomach cancer	0.0013	0.00135	CcSEcCtD
Ranolazine—Dry mouth—Docetaxel—stomach cancer	0.00129	0.00135	CcSEcCtD
Ranolazine—Haematuria—Epirubicin—stomach cancer	0.00128	0.00133	CcSEcCtD
Ranolazine—Confusional state—Docetaxel—stomach cancer	0.00128	0.00133	CcSEcCtD
Ranolazine—Anxiety—Capecitabine—stomach cancer	0.00128	0.00133	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.00127	0.00132	CcSEcCtD
Ranolazine—Urinary tract disorder—Methotrexate—stomach cancer	0.00127	0.00132	CcSEcCtD
Ranolazine—Epistaxis—Epirubicin—stomach cancer	0.00127	0.00132	CcSEcCtD
Ranolazine—Urethral disorder—Methotrexate—stomach cancer	0.00126	0.00131	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—stomach cancer	0.00126	0.00131	CcSEcCtD
Ranolazine—Dry mouth—Capecitabine—stomach cancer	0.00125	0.0013	CcSEcCtD
Ranolazine—Shock—Docetaxel—stomach cancer	0.00125	0.0013	CcSEcCtD
Ranolazine—Nervous system disorder—Docetaxel—stomach cancer	0.00124	0.00129	CcSEcCtD
Ranolazine—Pruritus—Fluorouracil—stomach cancer	0.00124	0.00129	CcSEcCtD
Ranolazine—Thrombocytopenia—Docetaxel—stomach cancer	0.00124	0.00129	CcSEcCtD
Ranolazine—Visual impairment—Methotrexate—stomach cancer	0.00124	0.00129	CcSEcCtD
Ranolazine—Confusional state—Capecitabine—stomach cancer	0.00124	0.00129	CcSEcCtD
Ranolazine—Skin disorder—Docetaxel—stomach cancer	0.00123	0.00128	CcSEcCtD
Ranolazine—Bradycardia—Epirubicin—stomach cancer	0.00123	0.00127	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—stomach cancer	0.00122	0.00127	CcSEcCtD
Ranolazine—Dizziness—Irinotecan—stomach cancer	0.00121	0.00126	CcSEcCtD
Ranolazine—Anorexia—Docetaxel—stomach cancer	0.00121	0.00126	CcSEcCtD
Ranolazine—Shock—Capecitabine—stomach cancer	0.00121	0.00126	CcSEcCtD
Ranolazine—Nervous system disorder—Capecitabine—stomach cancer	0.0012	0.00125	CcSEcCtD
Ranolazine—Eye disorder—Methotrexate—stomach cancer	0.0012	0.00125	CcSEcCtD
Ranolazine—Thrombocytopenia—Capecitabine—stomach cancer	0.0012	0.00125	CcSEcCtD
Ranolazine—Tinnitus—Methotrexate—stomach cancer	0.0012	0.00125	CcSEcCtD
Ranolazine—Hypoaesthesia—Epirubicin—stomach cancer	0.0012	0.00125	CcSEcCtD
Ranolazine—Cardiac disorder—Methotrexate—stomach cancer	0.00119	0.00124	CcSEcCtD
Ranolazine—Skin disorder—Capecitabine—stomach cancer	0.00119	0.00124	CcSEcCtD
Ranolazine—Urinary tract disorder—Epirubicin—stomach cancer	0.00119	0.00124	CcSEcCtD
Ranolazine—Hyperhidrosis—Capecitabine—stomach cancer	0.00119	0.00123	CcSEcCtD
Ranolazine—Oedema peripheral—Epirubicin—stomach cancer	0.00119	0.00123	CcSEcCtD
Ranolazine—Hypotension—Docetaxel—stomach cancer	0.00119	0.00123	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—stomach cancer	0.00118	0.00123	CcSEcCtD
Ranolazine—Connective tissue disorder—Epirubicin—stomach cancer	0.00118	0.00123	CcSEcCtD
Ranolazine—Urethral disorder—Epirubicin—stomach cancer	0.00118	0.00123	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—stomach cancer	0.00117	0.00122	CcSEcCtD
Ranolazine—Anorexia—Capecitabine—stomach cancer	0.00117	0.00122	CcSEcCtD
Ranolazine—Angiopathy—Methotrexate—stomach cancer	0.00117	0.00121	CcSEcCtD
Ranolazine—Vomiting—Irinotecan—stomach cancer	0.00117	0.00121	CcSEcCtD
Ranolazine—Dizziness—Fluorouracil—stomach cancer	0.00116	0.00121	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—stomach cancer	0.00116	0.00121	CcSEcCtD
Ranolazine—Mediastinal disorder—Methotrexate—stomach cancer	0.00116	0.00121	CcSEcCtD
Ranolazine—Rash—Irinotecan—stomach cancer	0.00116	0.0012	CcSEcCtD
Ranolazine—Dermatitis—Irinotecan—stomach cancer	0.00116	0.0012	CcSEcCtD
Ranolazine—Headache—Irinotecan—stomach cancer	0.00115	0.0012	CcSEcCtD
Ranolazine—Hypotension—Capecitabine—stomach cancer	0.00115	0.00119	CcSEcCtD
Ranolazine—Insomnia—Docetaxel—stomach cancer	0.00115	0.00119	CcSEcCtD
Ranolazine—Paraesthesia—Docetaxel—stomach cancer	0.00114	0.00118	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—stomach cancer	0.00113	0.00118	CcSEcCtD
Ranolazine—Dyspnoea—Docetaxel—stomach cancer	0.00113	0.00118	CcSEcCtD
Ranolazine—Somnolence—Docetaxel—stomach cancer	0.00113	0.00117	CcSEcCtD
Ranolazine—Mental disorder—Methotrexate—stomach cancer	0.00113	0.00117	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—stomach cancer	0.00113	0.00117	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—stomach cancer	0.00112	0.00117	CcSEcCtD
Ranolazine—Malnutrition—Methotrexate—stomach cancer	0.00112	0.00116	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—stomach cancer	0.00112	0.00116	CcSEcCtD
Ranolazine—Vomiting—Fluorouracil—stomach cancer	0.00112	0.00116	CcSEcCtD
Ranolazine—Dyspepsia—Docetaxel—stomach cancer	0.00112	0.00116	CcSEcCtD
Ranolazine—Insomnia—Capecitabine—stomach cancer	0.00111	0.00116	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—stomach cancer	0.00111	0.00115	CcSEcCtD
Ranolazine—Rash—Fluorouracil—stomach cancer	0.00111	0.00115	CcSEcCtD
Ranolazine—Dermatitis—Fluorouracil—stomach cancer	0.00111	0.00115	CcSEcCtD
Ranolazine—Paraesthesia—Capecitabine—stomach cancer	0.0011	0.00115	CcSEcCtD
Ranolazine—Decreased appetite—Docetaxel—stomach cancer	0.0011	0.00115	CcSEcCtD
Ranolazine—Headache—Fluorouracil—stomach cancer	0.0011	0.00114	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—stomach cancer	0.0011	0.00114	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—stomach cancer	0.0011	0.00114	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00109	0.00114	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—stomach cancer	0.00109	0.00114	CcSEcCtD
Ranolazine—Dyspnoea—Capecitabine—stomach cancer	0.00109	0.00114	CcSEcCtD
Ranolazine—Fatigue—Docetaxel—stomach cancer	0.00109	0.00114	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—stomach cancer	0.00109	0.00114	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—stomach cancer	0.00109	0.00114	CcSEcCtD
Ranolazine—Nausea—Irinotecan—stomach cancer	0.00109	0.00113	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—stomach cancer	0.00109	0.00113	CcSEcCtD
Ranolazine—Constipation—Docetaxel—stomach cancer	0.00108	0.00113	CcSEcCtD
Ranolazine—Dyspepsia—Capecitabine—stomach cancer	0.00108	0.00112	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—stomach cancer	0.00108	0.00112	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—stomach cancer	0.00107	0.00112	CcSEcCtD
Ranolazine—Decreased appetite—Capecitabine—stomach cancer	0.00107	0.00111	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00106	0.0011	CcSEcCtD
Ranolazine—Fatigue—Capecitabine—stomach cancer	0.00106	0.0011	CcSEcCtD
Ranolazine—Vision blurred—Methotrexate—stomach cancer	0.00106	0.0011	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—stomach cancer	0.00105	0.0011	CcSEcCtD
Ranolazine—Constipation—Capecitabine—stomach cancer	0.00105	0.00109	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—stomach cancer	0.00105	0.00109	CcSEcCtD
Ranolazine—Feeling abnormal—Docetaxel—stomach cancer	0.00105	0.00109	CcSEcCtD
Ranolazine—Nausea—Fluorouracil—stomach cancer	0.00104	0.00109	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—stomach cancer	0.00104	0.00108	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—stomach cancer	0.00104	0.00108	CcSEcCtD
Ranolazine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00104	0.00108	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—stomach cancer	0.00103	0.00108	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—stomach cancer	0.00103	0.00107	CcSEcCtD
Ranolazine—Feeling abnormal—Capecitabine—stomach cancer	0.00101	0.00105	CcSEcCtD
Ranolazine—Angiopathy—Doxorubicin—stomach cancer	0.00101	0.00105	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—stomach cancer	0.00101	0.00105	CcSEcCtD
Ranolazine—Vertigo—Methotrexate—stomach cancer	0.00101	0.00105	CcSEcCtD
Ranolazine—Gastrointestinal pain—Capecitabine—stomach cancer	0.001	0.00104	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—stomach cancer	0.001	0.00104	CcSEcCtD
Ranolazine—Abdominal pain—Docetaxel—stomach cancer	0.001	0.00104	CcSEcCtD
Ranolazine—Leukopenia—Methotrexate—stomach cancer	0.001	0.00104	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—stomach cancer	0.000995	0.00104	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—stomach cancer	0.000988	0.00103	CcSEcCtD
Ranolazine—Cough—Methotrexate—stomach cancer	0.000977	0.00102	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—stomach cancer	0.000976	0.00102	CcSEcCtD
Ranolazine—Urticaria—Capecitabine—stomach cancer	0.000976	0.00101	CcSEcCtD
Ranolazine—Abdominal pain—Capecitabine—stomach cancer	0.000971	0.00101	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—stomach cancer	0.00097	0.00101	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—stomach cancer	0.000956	0.000994	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000947	0.000985	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—stomach cancer	0.000942	0.000979	CcSEcCtD
Ranolazine—Syncope—Epirubicin—stomach cancer	0.00094	0.000978	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—stomach cancer	0.000938	0.000976	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—stomach cancer	0.000932	0.00097	CcSEcCtD
Ranolazine—Palpitations—Epirubicin—stomach cancer	0.000926	0.000963	CcSEcCtD
Ranolazine—Confusional state—Methotrexate—stomach cancer	0.000922	0.000959	CcSEcCtD
Ranolazine—Loss of consciousness—Epirubicin—stomach cancer	0.000921	0.000958	CcSEcCtD
Ranolazine—Cough—Epirubicin—stomach cancer	0.000915	0.000951	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—stomach cancer	0.000914	0.000951	CcSEcCtD
Ranolazine—Asthenia—Docetaxel—stomach cancer	0.00091	0.000946	CcSEcCtD
Ranolazine—Pruritus—Docetaxel—stomach cancer	0.000897	0.000933	CcSEcCtD
Ranolazine—Nervous system disorder—Methotrexate—stomach cancer	0.000896	0.000932	CcSEcCtD
Ranolazine—Thrombocytopenia—Methotrexate—stomach cancer	0.000895	0.000931	CcSEcCtD
Ranolazine—Anxiety—Epirubicin—stomach cancer	0.000889	0.000925	CcSEcCtD
Ranolazine—Skin disorder—Methotrexate—stomach cancer	0.000888	0.000923	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000886	0.000922	CcSEcCtD
Ranolazine—Hyperhidrosis—Methotrexate—stomach cancer	0.000884	0.000919	CcSEcCtD
Ranolazine—Asthenia—Capecitabine—stomach cancer	0.000881	0.000916	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—stomach cancer	0.000873	0.000908	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—stomach cancer	0.000871	0.000906	CcSEcCtD
Ranolazine—Anorexia—Methotrexate—stomach cancer	0.000871	0.000906	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—stomach cancer	0.00087	0.000905	CcSEcCtD
Ranolazine—Pruritus—Capecitabine—stomach cancer	0.000869	0.000904	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—stomach cancer	0.000868	0.000903	CcSEcCtD
Ranolazine—Confusional state—Epirubicin—stomach cancer	0.000863	0.000897	CcSEcCtD
Ranolazine—Palpitations—Doxorubicin—stomach cancer	0.000857	0.000891	CcSEcCtD
Ranolazine—Hypotension—Methotrexate—stomach cancer	0.000854	0.000888	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—stomach cancer	0.000852	0.000887	CcSEcCtD
Ranolazine—Cough—Doxorubicin—stomach cancer	0.000846	0.00088	CcSEcCtD
Ranolazine—Shock—Epirubicin—stomach cancer	0.000842	0.000875	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—stomach cancer	0.000839	0.000873	CcSEcCtD
Ranolazine—Dizziness—Docetaxel—stomach cancer	0.000839	0.000872	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—stomach cancer	0.000838	0.000871	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—stomach cancer	0.000831	0.000864	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—stomach cancer	0.000827	0.00086	CcSEcCtD
Ranolazine—Insomnia—Methotrexate—stomach cancer	0.000827	0.00086	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—stomach cancer	0.000823	0.000856	CcSEcCtD
Ranolazine—Paraesthesia—Methotrexate—stomach cancer	0.000821	0.000854	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00082	0.000853	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—stomach cancer	0.000815	0.000848	CcSEcCtD
Ranolazine—Dyspnoea—Methotrexate—stomach cancer	0.000815	0.000848	CcSEcCtD
Ranolazine—Somnolence—Methotrexate—stomach cancer	0.000813	0.000845	CcSEcCtD
Ranolazine—Dizziness—Capecitabine—stomach cancer	0.000812	0.000845	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—stomach cancer	0.000808	0.00084	CcSEcCtD
Ranolazine—Vomiting—Docetaxel—stomach cancer	0.000806	0.000839	CcSEcCtD
Ranolazine—Dyspepsia—Methotrexate—stomach cancer	0.000805	0.000837	CcSEcCtD
Ranolazine—Rash—Docetaxel—stomach cancer	0.0008	0.000832	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—stomach cancer	0.000799	0.000831	CcSEcCtD
Ranolazine—Dermatitis—Docetaxel—stomach cancer	0.000799	0.000831	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—stomach cancer	0.000798	0.00083	CcSEcCtD
Ranolazine—Decreased appetite—Methotrexate—stomach cancer	0.000795	0.000826	CcSEcCtD
Ranolazine—Headache—Docetaxel—stomach cancer	0.000795	0.000826	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000789	0.000821	CcSEcCtD
Ranolazine—Fatigue—Methotrexate—stomach cancer	0.000788	0.00082	CcSEcCtD
Ranolazine—Vomiting—Capecitabine—stomach cancer	0.000781	0.000812	CcSEcCtD
Ranolazine—Shock—Doxorubicin—stomach cancer	0.000779	0.00081	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—stomach cancer	0.000776	0.000807	CcSEcCtD
Ranolazine—Thrombocytopenia—Doxorubicin—stomach cancer	0.000775	0.000806	CcSEcCtD
Ranolazine—Rash—Capecitabine—stomach cancer	0.000774	0.000805	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—stomach cancer	0.000774	0.000805	CcSEcCtD
Ranolazine—Dermatitis—Capecitabine—stomach cancer	0.000774	0.000804	CcSEcCtD
Ranolazine—Headache—Capecitabine—stomach cancer	0.000769	0.0008	CcSEcCtD
Ranolazine—Skin disorder—Doxorubicin—stomach cancer	0.000769	0.0008	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—stomach cancer	0.000768	0.000799	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000765	0.000796	CcSEcCtD
Ranolazine—Dyspnoea—Epirubicin—stomach cancer	0.000763	0.000793	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—stomach cancer	0.000761	0.000791	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—stomach cancer	0.000755	0.000785	CcSEcCtD
Ranolazine—Nausea—Docetaxel—stomach cancer	0.000753	0.000784	CcSEcCtD
Ranolazine—Feeling abnormal—Methotrexate—stomach cancer	0.000753	0.000783	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—stomach cancer	0.000753	0.000783	CcSEcCtD
Ranolazine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000748	0.000777	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—stomach cancer	0.000744	0.000773	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—stomach cancer	0.00074	0.000769	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000739	0.000768	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—stomach cancer	0.000738	0.000767	CcSEcCtD
Ranolazine—Constipation—Epirubicin—stomach cancer	0.000732	0.000761	CcSEcCtD
Ranolazine—Nausea—Capecitabine—stomach cancer	0.000729	0.000759	CcSEcCtD
Ranolazine—Urticaria—Methotrexate—stomach cancer	0.000726	0.000755	CcSEcCtD
Ranolazine—Abdominal pain—Methotrexate—stomach cancer	0.000723	0.000752	CcSEcCtD
Ranolazine—Insomnia—Doxorubicin—stomach cancer	0.000716	0.000745	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—stomach cancer	0.000711	0.000739	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—stomach cancer	0.000706	0.000734	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—stomach cancer	0.000705	0.000733	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—stomach cancer	0.000704	0.000732	CcSEcCtD
Ranolazine—Gastrointestinal pain—Epirubicin—stomach cancer	0.0007	0.000728	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—stomach cancer	0.000697	0.000725	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—stomach cancer	0.000688	0.000716	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000683	0.000711	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—stomach cancer	0.000682	0.00071	CcSEcCtD
Ranolazine—Urticaria—Epirubicin—stomach cancer	0.00068	0.000707	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—stomach cancer	0.000677	0.000704	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—stomach cancer	0.000676	0.000703	CcSEcCtD
Ranolazine—Asthenia—Methotrexate—stomach cancer	0.000656	0.000682	CcSEcCtD
Ranolazine—Feeling abnormal—Doxorubicin—stomach cancer	0.000652	0.000678	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000647	0.000673	CcSEcCtD
Ranolazine—Pruritus—Methotrexate—stomach cancer	0.000647	0.000673	CcSEcCtD
Ranolazine—Urticaria—Doxorubicin—stomach cancer	0.000629	0.000654	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—stomach cancer	0.000626	0.000651	CcSEcCtD
Ranolazine—Asthenia—Epirubicin—stomach cancer	0.000614	0.000638	CcSEcCtD
Ranolazine—Pruritus—Epirubicin—stomach cancer	0.000605	0.000629	CcSEcCtD
Ranolazine—Dizziness—Methotrexate—stomach cancer	0.000605	0.000629	CcSEcCtD
Ranolazine—Vomiting—Methotrexate—stomach cancer	0.000581	0.000604	CcSEcCtD
Ranolazine—Rash—Methotrexate—stomach cancer	0.000576	0.000599	CcSEcCtD
Ranolazine—Dermatitis—Methotrexate—stomach cancer	0.000576	0.000599	CcSEcCtD
Ranolazine—Headache—Methotrexate—stomach cancer	0.000573	0.000596	CcSEcCtD
Ranolazine—Asthenia—Doxorubicin—stomach cancer	0.000568	0.000591	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—stomach cancer	0.000566	0.000588	CcSEcCtD
Ranolazine—Pruritus—Doxorubicin—stomach cancer	0.00056	0.000582	CcSEcCtD
Ranolazine—Vomiting—Epirubicin—stomach cancer	0.000544	0.000566	CcSEcCtD
Ranolazine—Nausea—Methotrexate—stomach cancer	0.000543	0.000565	CcSEcCtD
Ranolazine—Rash—Epirubicin—stomach cancer	0.000539	0.000561	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—stomach cancer	0.000539	0.00056	CcSEcCtD
Ranolazine—Headache—Epirubicin—stomach cancer	0.000536	0.000557	CcSEcCtD
Ranolazine—Dizziness—Doxorubicin—stomach cancer	0.000523	0.000544	CcSEcCtD
Ranolazine—Nausea—Epirubicin—stomach cancer	0.000508	0.000528	CcSEcCtD
Ranolazine—Vomiting—Doxorubicin—stomach cancer	0.000503	0.000523	CcSEcCtD
Ranolazine—Rash—Doxorubicin—stomach cancer	0.000499	0.000519	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—stomach cancer	0.000499	0.000519	CcSEcCtD
Ranolazine—Headache—Doxorubicin—stomach cancer	0.000496	0.000516	CcSEcCtD
Ranolazine—Nausea—Doxorubicin—stomach cancer	0.00047	0.000489	CcSEcCtD
